Sharps Technology and BONK Announce Staking Collaboration, Bridging Institutional Capital and Web3 Culture
Strategic Partnership Announcement: Sharps Technology has partnered with BONK to utilize BONK's liquid staking infrastructure as part of its treasury strategy, aiming to stake a portion of its SOL holdings to earn staking yields and enhance liquidity within the Solana ecosystem.
Investment and Treasury Strategy: Sharps Technology recently acquired over two million SOL, valued at over $400 million, and is focused on leveraging its digital asset treasury strategy to generate consistent on-chain yield while supporting the Solana blockchain's growth.
Trade with 70% Backtested Accuracy
Analyst Views on STSS
About STSS
About the author
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.
Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.
MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.
DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.
Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase
Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.
Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.
Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase
Strategic Collaboration: Sharps Technology, Inc. has partnered with Coinbase to enhance its Solana digital asset treasury strategy, having acquired over 2 million SOL valued at over $400 million.
Utilization of Coinbase Services: The collaboration will leverage Coinbase's custody infrastructure and OTC desk products, aiming to support the global adoption of digital assets while ensuring secure and regulated service.
Sharps Technology Initiates $100 Million Stock Buyback Program; Shares Rise in Pre-market Trading
Stock Repurchase Program: Sharps Technology, Inc. has authorized a stock repurchase program to buy back up to $100 million of its outstanding common stock, aiming to enhance shareholder value and manage its capital structure.
Market Reaction: Following the announcement, Sharps Technology's stock rose by 8.41% in pre-market trading, reaching $7.35 on the Nasdaq.
Sharps Technology Approves $100 Million Stock Repurchase Plan
Stock Repurchase Program: Sharps Technology (NASDAQ: STSS) has launched a stock repurchase program to buy back up to $100 million of its common stock, which is approximately 55.5% of its market cap of $180.35 million as of October 1, 2025.
Market Reaction: Following the announcement, shares of STSS increased by 1.92% in premarket trading on Thursday.
Sharps Technology Announces $100 Million Stock Repurchase Program
Stock Repurchase Program: Sharps Technology, Inc. announced a stock repurchase program to buy back up to $100 million of its outstanding common stock, aimed at enhancing shareholder value and demonstrating confidence in the company's growth prospects.
Digital Asset Strategy: The company has also initiated a digital asset treasury strategy, acquiring over 2 million SOL, the native digital asset of the Solana blockchain, to leverage capital markets for on-chain yield generation.
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.
Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.
MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.
DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.
Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase
Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.
Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.
Sharps Technology Expands Digital Asset Treasury Strategy with Coinbase
Strategic Collaboration: Sharps Technology, Inc. has partnered with Coinbase to enhance its Solana digital asset treasury strategy, having acquired over 2 million SOL valued at over $400 million.
Utilization of Coinbase Services: The collaboration will leverage Coinbase's custody infrastructure and OTC desk products, aiming to support the global adoption of digital assets while ensuring secure and regulated service.
Sharps Technology Initiates $100 Million Stock Buyback Program; Shares Rise in Pre-market Trading
Stock Repurchase Program: Sharps Technology, Inc. has authorized a stock repurchase program to buy back up to $100 million of its outstanding common stock, aiming to enhance shareholder value and manage its capital structure.
Market Reaction: Following the announcement, Sharps Technology's stock rose by 8.41% in pre-market trading, reaching $7.35 on the Nasdaq.
Sharps Technology Approves $100 Million Stock Repurchase Plan
Stock Repurchase Program: Sharps Technology (NASDAQ: STSS) has launched a stock repurchase program to buy back up to $100 million of its common stock, which is approximately 55.5% of its market cap of $180.35 million as of October 1, 2025.
Market Reaction: Following the announcement, shares of STSS increased by 1.92% in premarket trading on Thursday.
Sharps Technology Announces $100 Million Stock Repurchase Program
Stock Repurchase Program: Sharps Technology, Inc. announced a stock repurchase program to buy back up to $100 million of its outstanding common stock, aimed at enhancing shareholder value and demonstrating confidence in the company's growth prospects.
Digital Asset Strategy: The company has also initiated a digital asset treasury strategy, acquiring over 2 million SOL, the native digital asset of the Solana blockchain, to leverage capital markets for on-chain yield generation.
